Concepedia

Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation

Hongli Liu, Yan Chen, Guohui Cui, Jianfeng Zhou

Acta Pharmacologica Sinica · 2005 · 201 citations · 14 references

DOI

Concepts

References

14

Anticancer potential of curcumin: preclinical and clinical studies.

Bharat B. Aggarwal, Anushree Kumar, Alok C. Bharti · PubMed · 2003 · 2.6K citations

, , +15

Curcumin, a Novel p300/CREB-binding Protein-specific Inhibitor of Acetyltransferase, Represses the Acetylation of Histone/Nonhistone Proteins and Histone Acetyltransferase-dependent Chromatin Transcription

Karanam Balasubramanyam, Radhika A. Varier, Mohammad Altaf et al. · Journal of Biological Chemistry · 2004 · 819 citations · Full text

, , +14

Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.

John M. Mariadason, Georgia Corner, Leonard H. Augenlicht · PubMed · 2000 · 375 citations

, , +17

Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases

Erding Hu, Edward Dul, Chiu-Mei Sung et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 350 citations

, , +8

Cloning and Characterization of a Novel Human Class I Histone Deacetylase That Functions as a Transcription Repressor

Erding Hu, Zunxuan Chen, Todd A. Fredrickson et al. · Journal of Biological Chemistry · 2000 · 303 citations · Full text

, , +9